The Japan drug registration dossier requires documents including the Common Technical Document (CTD), which encompasses Module 1 (regional administrative information), Module 2 (summary documents), Module 3 (quality data), Module 4 (non-clinical study reports), and Module 5 (clinical study reports). Additional local regulatory forms and certifications are also needed.
